
<div id="jpedal" style="overflow: hidden; position: relative; width: 909px; height: 1195px;">
<style type="text/css" >
.t {
	-webkit-transform-origin: top left;
	-moz-transform-origin: top left;
	-o-transform-origin: top left;
	-ms-transform-origin: top left;
	-webkit-transform: scale(0.25);
	-moz-transform: scale(0.25);
	-o-transform: scale(0.25);
	-ms-transform: scale(0.25);
	z-index: 2;
	position:absolute;
	white-space:nowrap;
	overflow:visible;
}
</style>
<style type="text/css" >

#t1_1{left:64px;top:1156px;}
#t2_1{left:89px;top:1153px;}
#t3_1{left:97px;top:1156px;letter-spacing:0.4px;word-spacing:-0.1px;}
#t4_1{left:192px;top:1153px;}
#t5_1{left:199px;top:1156px;letter-spacing:-0.2px;word-spacing:0.5px;}
#t6_1{left:724px;top:1156px;letter-spacing:-0.1px;}
#t7_1{left:64px;top:654px;letter-spacing:0.1px;}
#t8_1{left:64px;top:672px;letter-spacing:0.5px;word-spacing:-0.3px;}
#t9_1{left:64px;top:690px;letter-spacing:1px;word-spacing:0.6px;}
#ta_1{left:64px;top:707px;letter-spacing:0.9px;word-spacing:0.3px;}
#tb_1{left:64px;top:724px;letter-spacing:-0.1px;word-spacing:-1.8px;}
#tc_1{left:64px;top:741px;letter-spacing:1.1px;word-spacing:0.4px;}
#td_1{left:64px;top:759px;letter-spacing:0.5px;word-spacing:-0.5px;}
#te_1{left:64px;top:776px;letter-spacing:1px;word-spacing:0.7px;}
#tf_1{left:64px;top:793px;letter-spacing:0.8px;}
#tg_1{left:111px;top:794px;}
#th_1{left:119px;top:793px;letter-spacing:1.4px;word-spacing:1.1px;}
#ti_1{left:64px;top:810px;letter-spacing:-0.3px;word-spacing:-1.8px;}
#tj_1{left:64px;top:828px;letter-spacing:1.3px;word-spacing:1px;}
#tk_1{left:64px;top:845px;letter-spacing:2.4px;word-spacing:3.2px;}
#tl_1{left:64px;top:862px;letter-spacing:1.6px;word-spacing:-2.3px;}
#tm_1{left:64px;top:880px;letter-spacing:2.5px;word-spacing:3px;}
#tn_1{left:64px;top:897px;letter-spacing:1.3px;word-spacing:1.2px;}
#to_1{left:64px;top:914px;letter-spacing:1.2px;word-spacing:1.1px;}
#tp_1{left:64px;top:931px;letter-spacing:0.2px;word-spacing:-0.6px;}
#tq_1{left:64px;top:949px;letter-spacing:-0.4px;word-spacing:-1.8px;}
#tr_1{left:64px;top:966px;word-spacing:-1px;}
#ts_1{left:333px;top:655px;letter-spacing:1.7px;word-spacing:1.8px;}
#tt_1{left:333px;top:672px;letter-spacing:0.6px;word-spacing:0.1px;}
#tu_1{left:333px;top:690px;letter-spacing:2.8px;}
#tv_1{left:333px;top:707px;letter-spacing:2.8px;word-spacing:3.7px;}
#tw_1{left:333px;top:724px;letter-spacing:1.4px;word-spacing:1.5px;}
#tx_1{left:333px;top:741px;letter-spacing:2.6px;}
#ty_1{left:385px;top:742px;}
#tz_1{left:394px;top:741px;letter-spacing:2.4px;word-spacing:3.4px;}
#t10_1{left:333px;top:759px;letter-spacing:0.9px;word-spacing:-2.4px;}
#t11_1{left:333px;top:776px;letter-spacing:1.3px;word-spacing:1.1px;}
#t12_1{left:333px;top:793px;letter-spacing:1.5px;word-spacing:1.6px;}
#t13_1{left:333px;top:810px;letter-spacing:2.1px;word-spacing:2.3px;}
#t14_1{left:333px;top:828px;letter-spacing:1.3px;word-spacing:1.3px;}
#t15_1{left:333px;top:845px;letter-spacing:-0.6px;word-spacing:-1.8px;}
#t16_1{left:439px;top:846px;}
#t17_1{left:446px;top:845px;letter-spacing:-0.6px;word-spacing:-1.8px;}
#t18_1{left:333px;top:862px;letter-spacing:2.1px;word-spacing:2.5px;}
#t19_1{left:333px;top:880px;letter-spacing:1.5px;word-spacing:1.6px;}
#t1a_1{left:333px;top:897px;letter-spacing:1.1px;word-spacing:0.9px;}
#t1b_1{left:333px;top:914px;letter-spacing:0.7px;}
#t1c_1{left:333px;top:931px;letter-spacing:-0.1px;word-spacing:-1.8px;}
#t1d_1{left:423px;top:932px;}
#t1e_1{left:430px;top:931px;letter-spacing:-0.2px;word-spacing:-1.5px;}
#t1f_1{left:333px;top:949px;letter-spacing:-0.4px;}
#t1g_1{left:392px;top:950px;}
#t1h_1{left:399px;top:949px;letter-spacing:-0.1px;word-spacing:-1.9px;}
#t1i_1{left:333px;top:966px;letter-spacing:-0.8px;word-spacing:-1.9px;}
#t1j_1{left:333px;top:983px;letter-spacing:-0.7px;word-spacing:-1.5px;}
#t1k_1{left:333px;top:1000px;letter-spacing:-0.4px;word-spacing:-1.5px;}
#t1l_1{left:333px;top:1018px;letter-spacing:0.5px;word-spacing:-0.4px;}
#t1m_1{left:333px;top:1035px;letter-spacing:0.3px;word-spacing:-0.3px;}
#t1n_1{left:333px;top:1052px;letter-spacing:-0.2px;word-spacing:-1.5px;}
#t1o_1{left:333px;top:1069px;letter-spacing:1.8px;word-spacing:1.8px;}
#t1p_1{left:333px;top:1087px;letter-spacing:0.2px;word-spacing:-0.6px;}
#t1q_1{left:333px;top:1104px;letter-spacing:-0.4px;}
#t1r_1{left:375px;top:1105px;}
#t1s_1{left:382px;top:1104px;letter-spacing:-0.4px;word-spacing:-1.8px;}
#t1t_1{left:602px;top:189px;letter-spacing:-0.2px;word-spacing:-1.7px;}
#t1u_1{left:602px;top:206px;letter-spacing:0.1px;word-spacing:-0.5px;}
#t1v_1{left:602px;top:224px;word-spacing:-1.2px;}
#t1w_1{left:615px;top:241px;letter-spacing:0.7px;word-spacing:0.2px;}
#t1x_1{left:602px;top:258px;letter-spacing:2.5px;word-spacing:3px;}
#t1y_1{left:602px;top:275px;letter-spacing:0.7px;word-spacing:-0.2px;}
#t1z_1{left:602px;top:293px;letter-spacing:2.9px;word-spacing:3.8px;}
#t20_1{left:602px;top:310px;letter-spacing:0.8px;word-spacing:0.2px;}
#t21_1{left:602px;top:327px;letter-spacing:1.5px;word-spacing:1.5px;}
#t22_1{left:602px;top:344px;letter-spacing:1.2px;word-spacing:1.1px;}
#t23_1{left:602px;top:362px;letter-spacing:2px;word-spacing:2.2px;}
#t24_1{left:602px;top:379px;letter-spacing:0.9px;word-spacing:0.6px;}
#t25_1{left:602px;top:396px;letter-spacing:-0.2px;}
#t26_1{left:615px;top:413px;letter-spacing:1px;word-spacing:0.7px;}
#t27_1{left:602px;top:431px;letter-spacing:1.1px;word-spacing:0.7px;}
#t28_1{left:602px;top:448px;letter-spacing:2px;word-spacing:2.5px;}
#t29_1{left:602px;top:465px;letter-spacing:1.5px;word-spacing:1.9px;}
#t2a_1{left:602px;top:482px;letter-spacing:1.8px;word-spacing:1.9px;}
#t2b_1{left:602px;top:500px;letter-spacing:0.7px;word-spacing:0.2px;}
#t2c_1{left:602px;top:517px;letter-spacing:0.1px;word-spacing:-0.6px;}
#t2d_1{left:602px;top:534px;letter-spacing:1.8px;word-spacing:1.8px;}
#t2e_1{left:602px;top:552px;letter-spacing:0.9px;word-spacing:0.6px;}
#t2f_1{left:602px;top:569px;letter-spacing:2.1px;word-spacing:2.4px;}
#t2g_1{left:602px;top:586px;letter-spacing:1.6px;word-spacing:1.5px;}
#t2h_1{left:602px;top:603px;letter-spacing:0.5px;}
#t2i_1{left:602px;top:621px;letter-spacing:1.2px;word-spacing:0.9px;}
#t2j_1{left:602px;top:638px;letter-spacing:0.4px;word-spacing:-0.2px;}
#t2k_1{left:602px;top:655px;letter-spacing:1.7px;word-spacing:2px;}
#t2l_1{left:602px;top:672px;letter-spacing:0.2px;word-spacing:-0.1px;}
#t2m_1{left:693px;top:673px;}
#t2n_1{left:700px;top:672px;letter-spacing:0.4px;word-spacing:-0.1px;}
#t2o_1{left:602px;top:690px;letter-spacing:0.6px;}
#t2p_1{left:602px;top:707px;letter-spacing:1.1px;}
#t2q_1{left:667px;top:708px;}
#t2r_1{left:676px;top:707px;letter-spacing:1.3px;word-spacing:1.2px;}
#t2s_1{left:602px;top:724px;letter-spacing:0.9px;word-spacing:0.3px;}
#t2t_1{left:602px;top:741px;letter-spacing:1.7px;word-spacing:2.1px;}
#t2u_1{left:602px;top:759px;letter-spacing:0.4px;word-spacing:-0.5px;}
#t2v_1{left:602px;top:776px;letter-spacing:0.7px;word-spacing:-0.9px;}
#t2w_1{left:602px;top:793px;letter-spacing:-0.5px;word-spacing:-1.2px;}
#t2x_1{left:602px;top:810px;letter-spacing:1.6px;word-spacing:1.6px;}
#t2y_1{left:602px;top:828px;letter-spacing:0.4px;word-spacing:-0.5px;}
#t2z_1{left:718px;top:829px;letter-spacing:0.3px;}
#t30_1{left:732px;top:828px;letter-spacing:0.4px;word-spacing:-0.5px;}
#t31_1{left:602px;top:845px;letter-spacing:1.6px;word-spacing:1.6px;}
#t32_1{left:602px;top:862px;letter-spacing:2px;word-spacing:2.3px;}
#t33_1{left:602px;top:880px;letter-spacing:0.3px;word-spacing:-0.3px;}
#t34_1{left:602px;top:897px;letter-spacing:-0.1px;word-spacing:-1.1px;}
#t35_1{left:602px;top:930px;letter-spacing:0.1px;word-spacing:-2.7px;}
#t36_1{left:602px;top:949px;letter-spacing:0.3px;word-spacing:0.3px;}
#t37_1{left:602px;top:966px;letter-spacing:1px;word-spacing:1.6px;}
#t38_1{left:602px;top:983px;letter-spacing:0.6px;word-spacing:0.6px;}
#t39_1{left:602px;top:1000px;letter-spacing:-1px;word-spacing:-1.7px;}
#t3a_1{left:687px;top:1001px;}
#t3b_1{left:694px;top:1000px;letter-spacing:-0.8px;word-spacing:-1.9px;}
#t3c_1{left:779px;top:1000px;letter-spacing:-1.2px;}
#t3d_1{left:805px;top:1001px;}
#t3e_1{left:811px;top:1000px;letter-spacing:-0.9px;}
#t3f_1{left:602px;top:1018px;letter-spacing:0.8px;word-spacing:0.9px;}
#t3g_1{left:602px;top:1035px;letter-spacing:0.9px;word-spacing:1.4px;}
#t3h_1{left:602px;top:1052px;letter-spacing:-1.2px;word-spacing:-2px;}
#t3i_1{left:602px;top:1069px;letter-spacing:-0.4px;word-spacing:-0.4px;}
#t3j_1{left:602px;top:1087px;word-spacing:-1.2px;}
#t3k_1{left:602px;top:1104px;letter-spacing:0.2px;word-spacing:0.7px;}
#t3l_1{left:658px;top:1105px;}
#t3m_1{left:666px;top:1104px;letter-spacing:0.6px;word-spacing:0.8px;}
#t3n_1{left:65px;top:194px;letter-spacing:0.1px;}
#t3o_1{left:65px;top:213px;letter-spacing:-2.7px;word-spacing:-6.9px;}
#t3p_1{left:65px;top:244px;letter-spacing:-2.7px;word-spacing:-5.1px;}
#t3q_1{left:65px;top:294px;letter-spacing:-0.4px;word-spacing:-2.3px;}
#t3r_1{left:65px;top:325px;letter-spacing:-0.7px;}
#t3s_1{left:116px;top:325px;letter-spacing:-0.7px;word-spacing:-2.5px;}
#t3t_1{left:65px;top:343px;letter-spacing:-0.7px;word-spacing:-2.5px;}
#t3u_1{left:65px;top:361px;letter-spacing:-0.7px;word-spacing:-2.5px;}
#t3v_1{left:65px;top:380px;letter-spacing:-0.7px;word-spacing:-2.4px;}
#t3w_1{left:65px;top:398px;letter-spacing:-0.7px;word-spacing:-2.5px;}
#t3x_1{left:65px;top:416px;letter-spacing:-0.7px;word-spacing:-3px;}
#t3y_1{left:65px;top:435px;letter-spacing:-0.8px;word-spacing:-2.5px;}
#t3z_1{left:65px;top:453px;letter-spacing:-0.7px;word-spacing:-2.5px;}
#t40_1{left:65px;top:471px;letter-spacing:-0.8px;word-spacing:-2.5px;}
#t41_1{left:65px;top:490px;letter-spacing:-0.8px;word-spacing:-2.4px;}
#t42_1{left:65px;top:508px;letter-spacing:-0.9px;word-spacing:-2.3px;}
#t43_1{left:65px;top:526px;letter-spacing:-0.7px;word-spacing:-2.4px;}
#t44_1{left:65px;top:545px;letter-spacing:-0.7px;word-spacing:-2.5px;}
#t45_1{left:65px;top:574px;letter-spacing:-0.3px;word-spacing:-1.7px;}
#t46_1{left:128px;top:574px;letter-spacing:-0.5px;}
#t47_1{left:153px;top:574px;letter-spacing:-0.7px;word-spacing:-1.3px;}
#t48_1{left:213px;top:574px;letter-spacing:-0.1px;}
#t49_1{left:219px;top:574px;letter-spacing:-0.1px;}
#t4a_1{left:232px;top:574px;letter-spacing:-0.2px;word-spacing:-1.6px;}
#t4b_1{left:65px;top:588px;letter-spacing:-0.1px;}
#t4c_1{left:65px;top:611px;letter-spacing:-0.1px;word-spacing:-2.1px;}
#t4d_1{left:65px;top:624px;letter-spacing:-0.5px;word-spacing:-1.8px;}
#t4e_1{left:65px;top:1012px;letter-spacing:-0.1px;word-spacing:-2px;}
#t4f_1{left:65px;top:1026px;letter-spacing:-0.4px;word-spacing:-2.1px;}
#t4g_1{left:65px;top:1039px;letter-spacing:-0.7px;word-spacing:-1.8px;}
#t4h_1{left:65px;top:1053px;letter-spacing:-0.4px;word-spacing:-2.1px;}
#t4i_1{left:65px;top:1067px;letter-spacing:-0.4px;word-spacing:-2.1px;}
#t4j_1{left:65px;top:1081px;letter-spacing:-0.6px;word-spacing:-1.9px;}
#t4k_1{left:65px;top:1094px;letter-spacing:-0.6px;word-spacing:-1.9px;}
#t4l_1{left:65px;top:1108px;letter-spacing:-0.4px;word-spacing:-2px;}
#t4m_1{left:62px;top:84px;letter-spacing:11.1px;}
#t4n_1{left:330px;top:1175px;}

.s20_1{
	FONT-SIZE: 42.8px;
	FONT-FAMILY: LMHOVE-Whitney-Light1;
	color: rgb(35,31,32);
}

.s12_1{
	FONT-SIZE: 55px;
	FONT-FAMILY: CBIJIW-ITCFranklinGothicStd-Me1;
	color: rgb(35,31,32);
}

.s14_1{
	FONT-SIZE: 42.8px;
	FONT-FAMILY: DJSPWU-ITCFranklinGothicStd-Bo1;
	color: rgb(35,31,32);
}

.s9_1{
	FONT-SIZE: 55px;
	FONT-FAMILY: CBIJIW-ITCFranklinGothicStd-Me1;
	color: rgb(123,97,151);
}

.s11_1{
	FONT-SIZE: 61.1px;
	FONT-FAMILY: CBIJIW-ITCFranklinGothicStd-Bo1;
	color: rgb(35,31,32);
}

.s13_1{
	FONT-SIZE: 55px;
	FONT-FAMILY: DJSPWU-ITCFranklinGothicStd-Bo1;
	color: rgb(35,31,32);
}

.s15_1{
	FONT-SIZE: 42.8px;
	FONT-FAMILY: CBIJIW-ITCFranklinGothicStd-Bo1;
	color: rgb(35,31,32);
}

.s16_1{
	FONT-SIZE: 42.8px;
	FONT-FAMILY: CBIJIW-ITCFranklinGothicStd-Me1;
	color: rgb(35,31,32);
}

.s17_1{
	FONT-SIZE: 42.8px;
	FONT-FAMILY: DJSPWU-ITCFranklinGothicStd-Bo1;
	color: rgb(87,88,90);
}

.s3_1{
	FONT-SIZE: 45.8px;
	FONT-FAMILY: CBIJIW-MinionPro-Medium1;
	color: rgb(35,31,32);
}

.s8_1{
	FONT-SIZE: 56.8px;
	FONT-FAMILY: CBIJIW-MinionPro-It1;
	color: rgb(35,31,32);
}

.s4_1{
	FONT-SIZE: 45.8px;
	FONT-FAMILY: CBIJIW-ITCFranklinGothicStd-Me1;
	color: rgb(35,31,32);
}

.s6_1{
	FONT-SIZE: 56.8px;
	FONT-FAMILY: CBIJIW-MinionPro-Regular1;
	color: rgb(35,31,32);
}

.s1_1{
	FONT-SIZE: 44.6px;
	FONT-FAMILY: CBIJIW-ITCFranklinGothicStd-De1;
	color: rgb(35,31,32);
}

.s18_1{
	FONT-SIZE: 45.8px;
	FONT-FAMILY: DJSPWU-ITCFranklinGothicStd-Bo1;
	color: rgb(35,31,32);
}

.s10_1{
	FONT-SIZE: 116.1px;
	FONT-FAMILY: CBIJIW-ITCFranklinGothicStd-Me1;
	color: rgb(35,31,32);
}

.s7_1{
	FONT-SIZE: 34.1px;
	FONT-FAMILY: CBIJIW-MinionPro-Regular1;
	color: rgb(35,31,32);
}

.s19_1{
	FONT-SIZE: 213.9px;
	FONT-FAMILY: DJSPWU-ITCFranklinGothicStd-Bo1;
	color: rgb(123,97,151);
}

.s2_1{
	FONT-SIZE: 52.7px;
	FONT-FAMILY: CBIJIW-MinionPro-Medium1;
	color: rgb(35,31,32);
}

.s5_1{
	FONT-SIZE: 61.1px;
	FONT-FAMILY: CBIJIW-ITCFranklinGothicStd-De1;
	color: rgb(35,31,32);
}

.v1_1{
	-webkit-transform: scale(0.108, 0.25);
	-ms-transform: scale(0.108, 0.25);
	-moz-transform: scale(0.108, 0.25);
	-o-transform: scale(0.108, 0.25);
}

.v2_1{
	-webkit-transform: scale(0.287, 0.25);
	-ms-transform: scale(0.287, 0.25);
	-moz-transform: scale(0.287, 0.25);
	-o-transform: scale(0.287, 0.25);
}

.v3_1{
	-webkit-transform: scale(0.225, 0.25);
	-ms-transform: scale(0.225, 0.25);
	-moz-transform: scale(0.225, 0.25);
	-o-transform: scale(0.225, 0.25);
}

#form1_1{	border-style:none;	z-index:2;	position: absolute;	left:64px;	top:588px;	width:144px;	height:14px;	text-align:left;	background: transparent;	font:normal 10px Arial, Helvetica, sans-serif;}

</style>
<style id="fonts1" type="text/css" >

@font-face {
	font-family: CBIJIW-MinionPro-It1;
	src: url("1/fonts/CBIJIW-MinionPro-It.woff") format("woff");
}

@font-face {
	font-family: CBIJIW-MinionPro-Regular1;
	src: url("1/fonts/CBIJIW-MinionPro-Regular.woff") format("woff");
}

@font-face {
	font-family: CBIJIW-ITCFranklinGothicStd-Bo1;
	src: url("1/fonts/CBIJIW-ITCFranklinGothicStd-Bo.woff") format("woff");
}

@font-face {
	font-family: CBIJIW-ITCFranklinGothicStd-Me1;
	src: url("1/fonts/CBIJIW-ITCFranklinGothicStd-Me.woff") format("woff");
}

@font-face {
	font-family: LMHOVE-Whitney-Light1;
	src: url("1/fonts/LMHOVE-Whitney-Light.woff") format("woff");
}

@font-face {
	font-family: CBIJIW-MinionPro-Medium1;
	src: url("1/fonts/CBIJIW-MinionPro-Medium.woff") format("woff");
}

@font-face {
	font-family: DJSPWU-ITCFranklinGothicStd-Bo1;
	src: url("1/fonts/DJSPWU-ITCFranklinGothicStd-Bo.woff") format("woff");
}

@font-face {
	font-family: CBIJIW-ITCFranklinGothicStd-De1;
	src: url("1/fonts/CBIJIW-ITCFranklinGothicStd-De.woff") format("woff");
}

</style>
<div id="t1_1" class="t s1_1">526</div>
<div id="t2_1" class="t v1_1 s2_1">|</div>
<div id="t3_1" class="t s3_1">SEPTEMBER 2014 </div>
<div id="t4_1" class="t v1_1 s2_1">|</div>
<div id="t5_1" class="t s3_1">VOLUME 11</div>
<div id="t6_1" class="t s4_1">www.nature.com/nrurol</div>
<div id="t7_1" class="t s5_1">Introduction</div>
<div id="t8_1" class="t s6_1">The benefits of testosterone supplementa-</div>
<div id="t9_1" class="t s6_1">tion therapy (TST) for hypogonadal men </div>
<div id="ta_1" class="t s6_1">are well described in the literature. These </div>
<div id="tb_1" class="t s6_1">benefits include increased libido, improved </div>
<div id="tc_1" class="t s6_1">erectile function, increased muscle mass, </div>
<div id="td_1" class="t s6_1">decreased adipose tissue, improved physi-</div>
<div id="te_1" class="t s6_1">cal strength, and improved bone mineral </div>
<div id="tf_1" class="t s6_1">density.</div>
<div id="tg_1" class="t s7_1">1</div>
<div id="th_1" class="t s6_1">Nevertheless, the use of TST in </div>
<div id="ti_1" class="t s6_1">men with prostate cancer remains a contro-</div>
<div id="tj_1" class="t s6_1">versial subject. Prostate cancer begins as </div>
<div id="tk_1" class="t s6_1">an androgen-dependent neoplasm and </div>
<div id="tl_1" class="t s6_1">androgen- deprivation therapy (ADT) is </div>
<div id="tm_1" class="t s6_1">widely used to slow tumour growth in </div>
<div id="tn_1" class="t s6_1">men with metastatic disease; conversely, </div>
<div id="to_1" class="t s6_1">supplementation of testosterone has his-</div>
<div id="tp_1" class="t s6_1">torically been thought to promote prostate </div>
<div id="tq_1" class="t s6_1">cancer growth and, therefore, apprehension </div>
<div id="tr_1" class="t s6_1">regarding TST in men with this disease has </div>
<div id="ts_1" class="t s6_1">persisted despite a recent accumulation </div>
<div id="tt_1" class="t s6_1">of evidence to the contrary. The concerns </div>
<div id="tu_1" class="t s6_1">that TST might cause prostate- cancer </div>
<div id="tv_1" class="t s6_1">progression originated in the seminal </div>
<div id="tw_1" class="t s6_1">work published in 1941 by Huggins and </div>
<div id="tx_1" class="t s6_1">Hodges,</div>
<div id="ty_1" class="t s7_1">2</div>
<div id="tz_1" class="t s6_1">part of Huggins’ research on </div>
<div id="t10_1" class="t s6_1">hormone- responsive cancer for which he </div>
<div id="t11_1" class="t s6_1">was eventually awarded the Nobel Prize. </div>
<div id="t12_1" class="t s6_1">These investigators found that reducing </div>
<div id="t13_1" class="t s6_1">serum testosterone to castrate levels in </div>
<div id="t14_1" class="t s6_1">patients with prostate cancer resulted in </div>
<div id="t15_1" class="t s6_1">tumour regression.</div>
<div id="t16_1" class="t s7_1">2</div>
<div id="t17_1" class="t s6_1">In addition, the authors </div>
<div id="t18_1" class="t s6_1">reported that, conversely, the adminis-</div>
<div id="t19_1" class="t s6_1">tration of testosterone to three patients, </div>
<div id="t1a_1" class="t s6_1">at least one of whom had been castrated, </div>
<div id="t1b_1" class="t s6_1">was associated with increases in prostate-</div>
<div id="t1c_1" class="t s6_1">cancer markers.</div>
<div id="t1d_1" class="t s7_1">2</div>
<div id="t1e_1" class="t s6_1">Later, in 1981, Fowler and </div>
<div id="t1f_1" class="t s6_1">Whitmore</div>
<div id="t1g_1" class="t s7_1">3</div>
<div id="t1h_1" class="t s6_1">reported that 45 of 52 men with </div>
<div id="t1i_1" class="t s6_1">metastatic prostate cancer had an ‘unfavour-</div>
<div id="t1j_1" class="t s6_1">able’ outcome after receiving exogenous tes-</div>
<div id="t1k_1" class="t s6_1">tosterone. However, 48 of the men included </div>
<div id="t1l_1" class="t s6_1">in this study had been androgen-deprived </div>
<div id="t1m_1" class="t s6_1">at the time of testosterone administration; </div>
<div id="t1n_1" class="t s6_1">notably, in three of the four eugonadal men </div>
<div id="t1o_1" class="t s6_1">assessed, the disease followed relatively </div>
<div id="t1p_1" class="t s6_1">benign courses after testosterone adminis-</div>
<div id="t1q_1" class="t s6_1">tration.</div>
<div id="t1r_1" class="t s7_1">3</div>
<div id="t1s_1" class="t s6_1">Thus, this report suggests that men </div>
<div id="t1t_1" class="t s6_1">on ADT respond differently to testosterone </div>
<div id="t1u_1" class="t s6_1">administration compared with moderately </div>
<div id="t1v_1" class="t s6_1">hypogonadal men.</div>
<div id="t1w_1" class="t s6_1">A plethora of studies on this topic have </div>
<div id="t1x_1" class="t s6_1">been published over the past 10 years, </div>
<div id="t1y_1" class="t s6_1">with the findings of most of these investi-</div>
<div id="t1z_1" class="t s6_1">gations supporting the safety of care-</div>
<div id="t20_1" class="t s6_1">fully administered and closely monitored </div>
<div id="t21_1" class="t s6_1">TST in hypogonadal patients with pros-</div>
<div id="t22_1" class="t s6_1">tate cancer. In fact, in the modern era of </div>
<div id="t23_1" class="t s6_1">PSA testing, no peer-reviewed publica-</div>
<div id="t24_1" class="t s6_1">tions have demonstrated that TST causes </div>
<div id="t25_1" class="t s6_1">prostate-cancer progression.</div>
<div id="t26_1" class="t s6_1">In this Perspectives article, we write in </div>
<div id="t27_1" class="t s6_1">support of the safety of TST in men with </div>
<div id="t28_1" class="t s6_1">prostate cancer or a history of prostate </div>
<div id="t29_1" class="t s6_1">cancer. Herein, we challenge the persis-</div>
<div id="t2a_1" class="t s6_1">tent historical urological paradigm that </div>
<div id="t2b_1" class="t s6_1">TST results in the progression of prostate </div>
<div id="t2c_1" class="t s6_1">cancer by highlighting the lack of evidence </div>
<div id="t2d_1" class="t s6_1">supporting this claim. Furthermore, we </div>
<div id="t2e_1" class="t s6_1">present contrary data indicating that low </div>
<div id="t2f_1" class="t s6_1">testosterone levels—not high testoster-</div>
<div id="t2g_1" class="t s6_1">one levels—might be associated with an </div>
<div id="t2h_1" class="t s6_1">increased risk of prostate cancer, and that </div>
<div id="t2i_1" class="t s6_1">TST can be safely administered to hypo-</div>
<div id="t2j_1" class="t s6_1">gonadal men with treated prostate cancer, </div>
<div id="t2k_1" class="t s6_1">or with caution in those with untreated </div>
<div id="t2l_1" class="t s6_1">prostate cancer.</div>
<div id="t2m_1" class="t s7_1">4</div>
<div id="t2n_1" class="t s6_1">Profoundly hypogonadal </div>
<div id="t2o_1" class="t s6_1">men, such as those studied by Fowler and </div>
<div id="t2p_1" class="t s6_1">Whitmore,</div>
<div id="t2q_1" class="t s7_1">3</div>
<div id="t2r_1" class="t s6_1">are beyond the scope of this </div>
<div id="t2s_1" class="t s6_1">article, and we focus instead on the more </div>
<div id="t2t_1" class="t s6_1">common situation of hypogonadal men </div>
<div id="t2u_1" class="t s6_1">with serum testosterone levels in excess of </div>
<div id="t2v_1" class="t s6_1">150–200 ng/dl and who have not received </div>
<div id="t2w_1" class="t s6_1">ADT. Importantly however, consistent with </div>
<div id="t2x_1" class="t s6_1">Endocrine Society Guidelines and AUA </div>
<div id="t2y_1" class="t s6_1">position statements,</div>
<div id="t2z_1" class="t s7_1">5,6</div>
<div id="t30_1" class="t s6_1">TST should only be </div>
<div id="t31_1" class="t s6_1">considered in men who have laboratory </div>
<div id="t32_1" class="t s6_1">evidence of low testosterone levels and </div>
<div id="t33_1" class="t s6_1">symptoms consistent with hypogonadism, </div>
<div id="t34_1" class="t s6_1">regardless of their prostate cancer status.</div>
<div id="t35_1" class="t s5_1">TST—effects on the prostate</div>
<div id="t36_1" class="t s6_1">The ‘prostate-saturation theory’ forms the </div>
<div id="t37_1" class="t s6_1">foundation for the contemporary under-</div>
<div id="t38_1" class="t s6_1">standing of the safety of TST in men with </div>
<div id="t39_1" class="t s6_1">prostate cancer.</div>
<div id="t3a_1" class="t s7_1">7</div>
<div id="t3b_1" class="t s6_1">In 2006, Marks </div>
<div id="t3c_1" class="t s8_1">et al.</div>
<div id="t3d_1" class="t s7_1">8</div>
<div id="t3e_1" class="t s6_1">inves-</div>
<div id="t3f_1" class="t s6_1">tigated the effects of testosterone therapy </div>
<div id="t3g_1" class="t s6_1">on normal prostate tissue. These authors </div>
<div id="t3h_1" class="t s6_1">studied TST in 44 men aged 44–78 years with </div>
<div id="t3i_1" class="t s6_1">symptomatic hypogonadism (serum testos-</div>
<div id="t3j_1" class="t s6_1">terone &lt;300 ng/dl), 40 of whom completed </div>
<div id="t3k_1" class="t s6_1">the study.</div>
<div id="t3l_1" class="t s7_1">8</div>
<div id="t3m_1" class="t s6_1">The patients were randomized </div>
<div id="t3n_1" class="t v2_1 s9_1">OPINION</div>
<div id="t3o_1" class="t s10_1">The safety of testosterone supplementation </div>
<div id="t3p_1" class="t s10_1">therapy in prostate cancer</div>
<div id="t3q_1" class="t s11_1">James M. Dupree, Gavin M. Langille, Mohit Khera and Larry I. Lipshultz</div>
<div id="t3r_1" class="t s12_1">Abstract</div>
<div id="t3s_1" class="t s13_1">| Patients with prostate cancer can present with hypogonadism and experience </div>
<div id="t3t_1" class="t s13_1">health and quality-of-life declines related to low testosterone levels. Despite generations </div>
<div id="t3u_1" class="t s13_1">of urological dogma suggesting that testosterone supplementation therapy (TST) for </div>
<div id="t3v_1" class="t s13_1">hypogonadism causes prostate-cancer progression, a review of the contemporary </div>
<div id="t3w_1" class="t s13_1">literature provides evidence to the contrary. The prostate saturation model suggests that </div>
<div id="t3x_1" class="t s13_1">the androgen receptor (AR) is saturated at serum testosterone levels of 150–200 ng/dl, </div>
<div id="t3y_1" class="t s13_1">and that additional serum testosterone above this level has limited, if any, effects within </div>
<div id="t3z_1" class="t s13_1">the prostate. Indeed, studies in the modern era of PSA assessments indicate that TST </div>
<div id="t40_1" class="t s13_1">does not affect prostate size, intraprostatic testosterone levels, or prostate-cancer </div>
<div id="t41_1" class="t s13_1">progression, provided the baseline serum testosterone level is greater than this AR </div>
<div id="t42_1" class="t s13_1">saturation point. However, the body of data on this subject comes from a small number </div>
<div id="t43_1" class="t s13_1">of cases, and TST should only be administered to patients with prostate cancer after </div>
<div id="t44_1" class="t s13_1">thorough discussions of the risks and benefits, with subsequent careful monitoring.</div>
<div id="t45_1" class="t s14_1">Dupree, J. M. </div>
<div id="t46_1" class="t s15_1">et al.</div>
<div id="t47_1" class="t s15_1">Nat. Rev. Urol</div>
<div id="t48_1" class="t s14_1">. </div>
<div id="t49_1" class="t s16_1">11</div>
<div id="t4a_1" class="t s14_1">, 526–530 (2014); published online 29 July 2014;  </div>
<div id="t4b_1" class="t s17_1">doi:10.1038/nrurol.2014.163</div>
<div id="t4c_1" class="t s14_1">This article forms part of a Point/Counterpoint discussion of the use of testosterone supplementation </div>
<div id="t4d_1" class="t s14_1">in prostate cancer.</div>
<div id="t4e_1" class="t s4_1">Competing interests</div>
<div id="t4f_1" class="t s18_1">M.K. declares that he has acted as a consultant </div>
<div id="t4g_1" class="t s18_1">for Auxillium, Merck, Meda, and Lilly. L.I.L. </div>
<div id="t4h_1" class="t s18_1">declares that he is a member of the speakers’ </div>
<div id="t4i_1" class="t s18_1">bureau and/or has received honouraria from, </div>
<div id="t4j_1" class="t s18_1">and has acted as a consultant for, Auxillium, </div>
<div id="t4k_1" class="t s18_1">Endo, Respro Therapeutics, and Lilly. J.M.D. </div>
<div id="t4l_1" class="t s18_1">and G.M.L. declare no competing interests.</div>
<div id="t4m_1" class="t v3_1 s19_1">PERSPECTIVES</div>
<div id="t4n_1" class="t s20_1">© 2014 Macmillan Publishers Limited. All rights reserved</div>

<form>
<input type="button"  tabindex="1"  id="form1_1" name="442 0 R"  pdfFieldName="442 0 R" onclick="window.open('http://www.nature.com/doifinder/10.1038/nrurol.2014.163','_blank');" style="cursor:pointer;" title="http://www.nature.com/doifinder/10.1038/nrurol.2014.163" />

</form>
<div id="pg1Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg1"><object width="909" height="1195" data="1/1.svg" type="image/svg+xml" id="pdf1" style="width:909px; height:1195px; background-color:white; -moz-transform:scale(1); z-index: 0;"></object></div>
<!--[if lt IE 9]><script type="text/javascript">
var divCount = 168;
for (var i = 1; i < divCount; i++) {
    var div = document.getElementById("t" + i.toString(36) + "_1");
    if (div !== null) {
        div.style.top = (div.offsetTop * 4) + "px";
        div.style.left = (div.offsetLeft * 4) + "px";
        div.style.zoom = "25%";
    }
}
</script><![endif]-->

</div>
